These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10844911)

  • 41. Screening for hemochromatosis: phenotype versus genotype.
    Edwards CQ; Griffen LM; Ajioka RS; Kushner JP
    Semin Hematol; 1998 Jan; 35(1):72-6. PubMed ID: 9460810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Novel Approach to Improving Utilization of Laboratory Testing.
    Zhou Y; Procop GW; Riley JD
    Arch Pathol Lab Med; 2018 Feb; 142(2):243-247. PubMed ID: 28981372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for C282Y homozygosity in a Norwegian population (HUNT2): The sensitivity and specificity of transferrin saturation.
    Thorstensen K; Kvitland MA; Irgens WØ; Hveem K; Asberg A
    Scand J Clin Lab Invest; 2010 Apr; 70(2):92-7. PubMed ID: 20073670
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent advances in hemochromatosis: a 2015 update : a summary of proceedings of the 2014 conference held under the auspices of Hemochromatosis Australia.
    Ekanayake D; Roddick C; Powell LW
    Hepatol Int; 2015 Apr; 9(2):174-82. PubMed ID: 25788196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Diagnosis and treatment of primary hemochromatosis].
    Swinkels DW; Marx JJ
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1404-8. PubMed ID: 10422553
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hereditary hemochromatosis screening: effect of mutation penetrance and prevalence on cost-effectiveness of testing algorithms.
    Gagné G; Reinharz D; Laflamme N; Adams PC; Rousseau F
    Clin Genet; 2007 Jan; 71(1):46-58. PubMed ID: 17204047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Screening for hereditary hemochromatosis].
    Birgens HS; Hansen NE
    Ugeskr Laeger; 2002 Jun; 164(23):3083-4; discussion 3084-5. PubMed ID: 12082869
    [No Abstract]   [Full Text] [Related]  

  • 48. [Screening for hereditary hemochromatosis?].
    Møller P
    Tidsskr Nor Laegeforen; 2005 Apr; 125(8):1044-5; author reply 1045. PubMed ID: 15852086
    [No Abstract]   [Full Text] [Related]  

  • 49. [Hereditary hemochromatosis--new developments after discovery of the HFE gene].
    Erhardt A; Niederau C; Osman Y; Häussinger D
    Z Gastroenterol; 1999 Dec; 37(12):1179-85. PubMed ID: 10666843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Screening for hereditary hemochromatosis?].
    Asberg A
    Tidsskr Nor Laegeforen; 2005 Jan; 125(1):15. PubMed ID: 15643454
    [No Abstract]   [Full Text] [Related]  

  • 51. Hemochromatosis. Common genes, uncommon illness?
    Harrison H; Adams PC
    Can Fam Physician; 2002 Aug; 48():1326-33. PubMed ID: 12228962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Finding the iron in the melting pot--practical use of a new genetic assay for hereditary hemochromatosis.
    Glenn JS; Cheung RC
    West J Med; 1998 Jun; 168(6):525-7. PubMed ID: 9655998
    [No Abstract]   [Full Text] [Related]  

  • 53. Transferrin saturation should not be corrected for body mass index in screening studies for haemochromatosis.
    Thorstensen K; Asberg A
    J Hepatol; 2006 May; 44(5):1003-4. PubMed ID: 16551484
    [No Abstract]   [Full Text] [Related]  

  • 54. Unsaturated iron binding capacity and transferrin saturation are equally reliable in detection of HFE hemochromatosis.
    Murtagh LJ; Whiley M; Wilson S; Tran H; Bassett ML
    Am J Gastroenterol; 2002 Aug; 97(8):2093-9. PubMed ID: 12190182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101,168 participants in the hemochromatosis and iron overload screening (HEIRS) study.
    Adams PC; Reboussin DM; Leiendecker-Foster C; Moses GC; McLaren GD; McLaren CE; Dawkins FW; Kasvosve I; Acton RT; Barton JC; Zaccaro D; Harris EL; Press R; Chang H; Eckfeldt JH
    Clin Chem; 2005 Jun; 51(6):1048-52. PubMed ID: 15833784
    [No Abstract]   [Full Text] [Related]  

  • 56. Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri.
    McDonnell SM; Hover A; Gloe D; Ou CY; Cogswell ME; Grummer-Strawn L
    Am J Med; 1999 Jul; 107(1):30-7. PubMed ID: 10403350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The value of iron determination. Comment on Hermann Heimpel, Martin Riedel, Roman Wennauder, Lothar Thomas: Plasma iron determination--useful, unnecessary or misleading?].
    Teich N; Mossner J
    Med Klin (Munich); 2003 Jul; 98(7):398-9. PubMed ID: 14723238
    [No Abstract]   [Full Text] [Related]  

  • 58. Diagnosis and management of hereditary haemochromatosis.
    van Bokhoven MA; van Deursen CT; Swinkels DW
    BMJ; 2011 Jan; 342():c7251. PubMed ID: 21248018
    [No Abstract]   [Full Text] [Related]  

  • 59. A pigmented octogenarian.
    Wolf M; Brice SE; Fertleman M
    Age Ageing; 2010 May; 39(3):400-1. PubMed ID: 20215121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hereditary hemochromatosis: presentation and diagnosis in the 1990s.
    Bacon BR; Sadiq SA
    Am J Gastroenterol; 1997 May; 92(5):784-9. PubMed ID: 9149185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.